George Bakris to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications George Bakris has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.695
-
Lipid disorders in uremia and dialysis. Contrib Nephrol. 2012; 178:100-105.
Score: 0.320
-
Effects of combining simvastatin with rosiglitazone on inflammation, oxidant stress and ambulatory blood pressure in patients with the metabolic syndrome: the SIROCO study. Diabetes Obes Metab. 2012 Feb; 14(2):181-6.
Score: 0.308
-
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. J Clin Hypertens (Greenwich). 2006 Aug; 8(8):571-81; quiz 582-3.
Score: 0.053
-
Is it time for a cardiovascular primary prevention trial in the elderly? Stroke. 2007 Feb; 38(2):441-50.
Score: 0.014